Found: 18
Select item for more details and to access through your institution.
Apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 6, p. 635, doi. 10.1002/ajh.25459
- By:
- Publication type:
- Article
Successful autologous stem cell transplantation in Gaucher disease patient with multiple myeloma.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 6, p. 529, doi. 10.1002/ajh.22028
- By:
- Publication type:
- Article
Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00805-x
- By:
- Publication type:
- Article
Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00375-2
- By:
- Publication type:
- Article
Association between the SDF1-3′A allele and high levels of CD34<sup>+</sup> progenitor cells mobilized into peripheral blood in humans.
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 1, p. 247, doi. 10.1046/j.1365-2141.2001.02717.x
- By:
- Publication type:
- Article
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE‐MM2 trial.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 995, doi. 10.1002/jha2.759
- By:
- Publication type:
- Article
Primary solitary plasmacytoma of the liver - successful treatment with fractionated stereotactic radiotherapy (Cyberknife®): a case report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Low-dose vs. high-dose thalidomide for advanced multiple myeloma: a prospective trial from the Intergroupe Francophone du Myélome.
- Published in:
- European Journal of Haematology, 2012, v. 88, n. 3, p. 249, doi. 10.1111/j.1600-0609.2011.01729.x
- By:
- Publication type:
- Article
Multiple myeloma in elderly patients: presenting features and outcome.
- Published in:
- European Journal of Haematology, 2001, v. 66, n. 1, p. 11, doi. 10.1034/j.1600-0609.2001.00301.x
- By:
- Publication type:
- Article
No survival improvement in patients with high‐risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 635, doi. 10.1111/bjh.17488
- By:
- Publication type:
- Article
Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 5, p. 783, doi. 10.1111/bjh.14483
- By:
- Publication type:
- Article
Could a citrus keep the haematologist away?
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 2, p. 298, doi. 10.1111/bjh.12840
- By:
- Publication type:
- Article
CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia.
- Published in:
- FASEB Journal, 2006, v. 20, n. 11, p. 1913, doi. 10.1096/fj.05-5667fje
- By:
- Publication type:
- Article
Characteristics, combinations, treatments, and survival of second primary hematological neoplasm: a retrospective single-center cohort of 49 patients (Hemo<sup>2</sup>study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Salvage therapy post pomalidomide-based regimen in relapsed/refractory myeloma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Interferon alpha with or without rituximab achieves a high response rate and durable responses in relapsed FL: 17 years' experience in a single centre.
- Published in:
- 2014
- By:
- Publication type:
- journal article